Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome-Reference-Cited by-同舟云学术

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome

Published:2021-03 Issue: Volume:9 Page:24-27
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Breen Ilana D.,Brumfiel Caitlin M.,Patel Meera H.,Rosenthal Allison C.,Rule William G.,DiCaudo David J.,Craig Fiona E.,Pittelkow Mark R.,Mangold Aaron R.

Publisher

Elsevier BV

Subject

Dermatology

Reference8 articles.

1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial;Kim;Lancet Oncol,2018

2. Stevens-Johnson syndrome associated with mogamulizumab treatment of adult T-cell leukemia/lymphoma;Ishida;Cancer Sci,2013

3. Histopathologic characterization of mogamulizumab-associated rash;Wang;Am J Surg Pathol,2020

4. Mogamulizumab-associated cutaneous granulomatous drug eruption mimicking mycosis fungoides but possibly indicating durable clinical response;Chen;JAMA Dermatol,2019

5. Methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation;Nassar;J Transplant,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments;Antibodies;2024-04-22

2. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review;International Journal of Molecular Sciences;2024-02-12

3. Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review;Journal of the European Academy of Dermatology and Venereology;2024-01-26

4. The potential association between extracorporeal photopheresis and thrombosis;Bone Marrow Transplantation;2023-11-23

5. The diverse landscape of dermatologic toxicities of non‐immune checkpoint inhibitor monoclonal antibody‐based cancer therapy;Journal of Cutaneous Pathology;2022-10-03